A Study of T-20 in HIV-Positive Adults
Public ClinicalTrials.gov record NCT00002228. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Evaluation of the Safety, Plasma Pharmacokinetics, and Antiviral Activity of T-20 Administered to HIV-1 Positive Adults By Continuous Subcutaneous Infusion or Subcutaneous Injection
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to see if it is safe and effective to give T-20 to HIV-positive adults. T-20 is an anti-HIV drug.
Study identification
- NCT ID
- NCT00002228
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 78 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 23, 2005
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Univ of Alabama at Birmingham / 1917 AIDS O/P Cln | Birmingham | Alabama | 35294 | — |
| UCLA School of Medicine / Ctr for Research and Education | Los Angeles | California | 900951793 | — |
| San Francisco Gen Hosp | San Francisco | California | 94110 | — |
| Quest Clinical Research | San Francisco | California | 94115 | — |
| IDC Research Initiative | Altamonte Springs | Florida | 32701 | — |
| Northwestern Univ / Infect Dis Div / Pasavant Pav 828 | Chicago | Illinois | 60611 | — |
| Johns Hopkins Hosp | Baltimore | Maryland | 21287 | — |
| CRI of New England | Brookline | Massachusetts | 02445 | — |
| NYU Med Ctr / C & D Building | New York | New York | 10016 | — |
| Univ North Carolina at Chapel Hill / Dept of Medicine | Chapel Hill | North Carolina | 27599 | — |
| Univ of Texas / Thomas Street Clinic | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00002228, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2005 · Synced Sep 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00002228 live on ClinicalTrials.gov.